TNYA
Tenaya Therapeutics, Inc.
$0.79
+0.04 (+5.50%)
At close · Jul 2
Market Cap
$170.76M
Shares
216,998,876
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Tomohiro Higa | acting interim Principal Accounting Officer | Resigned | 2026-06-29 |
| Faraz Ali | interim Principal Financial Officer | Resigned | 2026-06-29 |
| Eric Hyllengren | Chief Financial Officer | Appointed | 2026-06-29 |
| Catherine Stehman-Breen | Class II Director | Appointed | 2026-05-29 |
| Karah Parschauer | Class II Director | Appointed | 2026-05-29 |
| Amy Burroughs | Class II Director | Appointed | 2026-05-29 |